Table 3.
Summary of chest CT findings in 24 children with COVID-2019, reviewed in consensus by three paediatric radiologists with 10, 15 and 43 years of experience
| Abnormal CT scans | n = 22 (92%) |
| Median age (interquartile range, range) | 13.5 years (10.3 to 15.7 years, 6 months–17.3 years) |
| Male/female distribution | 50/50 |
| Scan indications (percentage) |
10 assessment of lower respiratory tract infection 10 (42%) 10 assessment of complications (42%) 4 COVID-19 polymerase chain reaction test positive (17%) |
|
Interval between symptoms and CT Mean (median, range) |
4.8 days (3.5, 0–12) |
| Comorbidities (percentage) |
19 none (79%) 3 congenital heart disease (13%) 2 immunocompromised status (8%) |
| Ground glass opacities (percentage) |
21 (88%) 15 bilateral (63%) 17 left lower lobe (71%), 17 right lower lobe (71%) 9 segmental distribution (43%) 7 rounded morphology (29%) |
| Consolidations (percentage) |
14 (58%) 8/14 bilateral (57%) 10/14 left lower lobe (71%), 9/14 right lower lobe (64%) 8/14 segmental distribution (57%) |
| Linear opacities (percentage) |
8 (33%) 5/8 unilateral (63%) 6/8 right lower lobe (75%), 5/8 left lower lobe (63%) 6/8 vertical orientation (75%) |
| Nodules (percentage) |
6 (25%) 5/6 unilateral (83%) 3/6 right lower lobe (50%), 3/6 left lower lobe (50%), 3/6 right upper lobe (50%) 3/6 central distribution (50%) |
| Tree in bud appearance | 6/24 (25%) |
| Lymphadenopathy (percentage) |
4 (17%) 2/4 hilar (50%) 2/4 mediastinal (50%) |
| Vascular engorgement (percentage) | 3 (13%) |
| Crazy paving (percentage) |
2 (8%) 1/2 bilateral (50%) 2/2 right upper lobe and right lower lobe (100%) |